ACTIVE

OSIVAX Belgique

Export PDF
Financial year 2024 · closed on 31/12/2024
Net result
-2,6 M €
+10.7% YoY
Gross margin
1,1 M €
+3.0% YoY
Equity
16,2 M €
+81.3% YoY
Workforce
7,1 ETP
+14.5% YoY

What does OSIVAX Belgique do?

OSIVAX Belgique is a Private limited company incorporated in 2018. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 7,1 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0707.772.871
Incorporation
04/10/2018
Legal form
Private limited company
Registered office
Rue des Chasseurs-Ardennais 7
4031 Liège · WallonieSee on map
Contributed capital
30 902 642,00 €
Latest accounts
31/12/2024
Average workforce
7,1 ETP
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main72110Research and experimental development on biotechnology
Joint committees (1)
  • 200
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20242023202220212019
Income statement
Gross margin1,1 M €1,1 M €1,8 M €850,5 k €-1,2 M €
EBITDA146,6 k €604,8 k €1,4 M €565,3 k €-1,3 M €
Operating result-3,3 M €-2,9 M €-2,9 M €-2,1 M €-1,4 M €
Net result-2,6 M €-2,9 M €-2,9 M €-2,1 M €-1,4 M €
Balance sheet
Equity16,2 M €8,9 M €10,9 M €10,4 M €188,3 k €
Total assets18,4 M €11,1 M €14,5 M €13,0 M €2,0 M €
Cash664,8 k €695,5 k €1,1 M €601,1 k €595,4 k €
Debts2,2 M €2,2 M €3,6 M €2,6 M €1,8 M €
Other
Workforce7,1 ETP6,2 ETP4,7 ETP4,6 ETP1,1 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 7 ended

Active mandates

Luzac Innovation

Director · since 24 décembre 2020

Represented by Alexandre Levert

Active
ALEXANDRE LE VERT

Director · since 24 septembre 2020

Active

Ended mandates

HLB NICOLET & C°

Registered auditor · since 31 mars 2021 · until 17 juin 2023 · 0876.193.377

Represented by Jean NICOLET

Ended
LUZAC Innovation

Director · since 24 décembre 2020

Represented by Alexandre LEVERT

Ended
LUZAC INNOVATION

Director · since 24 décembre 2020

Represented by LEVERT ALEXANDRE

Ended
OSIVAX SAS

Director · since 24 décembre 2020

Represented by LEVERT ALEXANDRE

Ended
Annual accounts

Full financial information

202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202028/09/2018
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months16 months
Filing date24/06/202526/08/202419/09/202331/08/202219/07/202117/07/2020
General meeting20/06/202521/06/202416/06/202317/06/202218/06/202119/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

6 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202420/06/202524/06/2025FrenchPDF
Abridged model31/12/202321/06/202426/08/2024FrenchPDF
Abridged model31/12/202216/06/202319/09/2023FrenchPDF
Abridged model31/12/202117/06/202231/08/2022FrenchPDF
Abridged model31/12/202018/06/202119/07/2021FrenchPDF
Abridged model31/12/201919/06/202017/07/2020FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 7 ended

Active mandates

Luzac Innovation

Director · since 24 décembre 2020

Represented by Alexandre Levert

Active
ALEXANDRE LE VERT

Director · since 24 septembre 2020

Active

Ended mandates

HLB NICOLET & C°

Registered auditor · since 31 mars 2021 · until 17 juin 2023 · 0876.193.377

Represented by Jean NICOLET

Ended
LUZAC Innovation

Director · since 24 décembre 2020

Represented by Alexandre LEVERT

Ended
LUZAC INNOVATION

Director · since 24 décembre 2020

Represented by LEVERT ALEXANDRE

Ended
OSIVAX SAS

Director · since 24 décembre 2020

Represented by LEVERT ALEXANDRE

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other10/12/2024
    DIVERS
    PDF
  • Mandates26/06/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Other12/09/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates11/05/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office05/05/2021
    SIEGE SOCIAL
    PDF
  • Mandates12/01/2021
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF
  • Mandates27/11/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/03/2020
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-2,6 M €↑
  2. 2023
    Annual accounts 2023-2,9 M €↑
  3. 2022
    Annual accounts 2022-2,9 M €↓
  4. 2021
    Annual accounts 2021-2,1 M €↓
  5. 2019
    Annual accounts 2019-1,4 M €
  6. 04/10/2018
    IncorporationPrivate limited company